RxDoctor Payments DataLook up a doctor →

George Waterfallen, MD

General Practice · Bastrop, LANPI 1831123132

Payments from drug & device makers

$4,405in general payments, 2019–2025

Across 386 payments — averaging $11.41 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • GSK$2K
  • AbbVie$537
  • Merck$273
  • Lilly USA, LLC$195
  • AstraZeneca$172
  • Bayer$150
  • plus $1K from 34 others

What the payments were for

  • Food & beverage$4,405100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$4,405 in reported general payments places this provider in the 95th percentile of 1,221 general practice providers in Louisiana.

See all general practice providers in Louisiana

Medicare billing

Part B allowed, 2024
$198,694
Medicare patients
167
Services billed
8,285

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Trelegy ElliptaFluticasone/Umeclidin/Vilanter244$200,204
MounjaroTirzepatide82$131,701
OzempicSemaglutide70$71,764
TrulicityDulaglutide43$57,507
EliquisApixaban57$41,269
LinzessLinaclotide59$40,288
JardianceEmpagliflozin42$36,642
FarxigaDapagliflozin Propanediol39$30,291
CreonLipase/Protease/Amylase21$27,639
RexultiBrexpiprazole11$23,738
Oxymorphone Hcl ErOxymorphone Hcl21$22,613
EntrestoSacubitril/Valsartan34$21,749
OxycontinOxycodone Hcl12$19,853
Nurtec OdtRimegepant Sulfate14$18,188
MyrbetriqMirabegron24$12,180

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
GSKTrelegy Ellipta, Anoro Ellipta$1,608$208,207259 claims
Lilly USA, LLCMounjaro, Trulicity$195$189,208125 claims
Novo NordiskOzempic$131$71,76470 claims
AbbVieLinzess, Creon$537$67,92780 claims
PfizerEliquis, Nurtec Odt$99$59,45771 claims
AstraZenecaFarxiga, Breztri Aerosphere, Symbicort$172$42,66466 claims
Boehringer IngelheimJardiance$24$36,64242 claims
Otsuka America Pharmaceutical, Inc.Rexulti$15$23,73811 claims
NovartisEntresto$11$21,74934 claims
MerckJanuvia, Belsomra$273$17,28934 claims
Astellas Pharma US IncMyrbetriq$50$12,18024 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 1,221 general practice providers in Louisiana.

Other general practice in Bastrop

See the full list for Louisiana

Where these figures come from

Is this you, or does something look wrong? →